BioSpace News Archive

Press Releases

Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAAI 2026

March 2, 2026
·
10 min read
Press Releases

LeMaitre to Participate at Upcoming Investor Conferences in March 2026

March 2, 2026
·
1 min read
Press Releases

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab - February 27, 2026

March 2, 2026
·
4 min read
Press Releases

Excellergy Presents New Data at 2026 AAAAI Annual Meeting Demonstrating Rapid and Sustained Allergic Effector Cell Control and Announces First Subjects Dosed in Phase 1 DISARM Trial

March 2, 2026
·
4 min read
Press Releases

Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome

March 2, 2026
·
5 min read
Press Releases

NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update

March 2, 2026
·
5 min read
Press Releases

Arcutis Management to Present at TD Cowen’s 46th Annual Health Care Conference

March 2, 2026
·
2 min read
Press Releases

FDA approves Novo Nordisk’s Sogroya® as the first and only once-weekly, long-acting growth hormone for three additional pediatric indications

March 2, 2026
·
13 min read
Press Releases

FCS Foundation Marks Rare Disease Day to Elevate Awareness and Support for Families Living with Familial Chylomicronemia Syndrome

March 2, 2026
·
1 min read
Press Releases

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 2, 2026
·
1 min read